ERBB2 and breast carcinoma: We assessed the survival outcomes of breast cancer patients using Kaplan-Meier curves (http://kmplot.com/analysis/) and found that higher-expressed HER2 (Fig 1A) or higher-expressed miR-4728 (Fig 1B) resulted in worse overall survival (OS).